Press Releases | Tenax Therapeutics Investor Center

Press Releases

8/11/16 6:00 am EDT
Tenax Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
8/3/16 5:00 pm EDT
Tenax Therapeutics to Discuss Second Quarter 2016 Financial Results and Provide Business Update
5/19/16 6:30 am EDT
Tenax Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update
5/10/16 7:30 am EDT
Tenax Therapeutics to Discuss First Quarter 2016 Financial Results and Provide Business Update
3/16/16 6:00 am EDT
Tenax Therapeutics Announces 2015 Transitional Report and Provides Corporate Update
3/9/16 5:30 pm EST
Tenax Therapeutics to Provide 2015 Transitional Report and Business Update
3/1/16 5:30 pm EST
Tenax Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
2/4/16 7:30 am EST
Tenax Therapeutics to Present at Leerink Partners 5th Annual Global Healthcare Conference
2/1/16 7:30 am EST
Tenax Therapeutics Provides Update of Phase 3 LEVO-CTS Trial for LCOS
12/22/15 7:30 am EST
Tenax Therapeutics Highlights Completion of Enrollment for LeoPARDS Trial by Imperial College London
12/15/15 6:00 am EST
Tenax Therapeutics Announces Second Quarter Fiscal Year 2016 Financial Results
12/8/15 4:30 pm EST
Tenax Therapeutics to Provide Corporate Update and Discuss Second Quarter Fiscal Year 2016 Financial Results on December 15, 2015
10/8/15 7:30 am EDT
Tenax Therapeutics Provides Clinical Update for Lead Candidate Levosimendan
9/22/15 7:30 am EDT
Tenax Therapeutics to Present at Ladenburg Thalmann 2015 Healthcare Conference
9/14/15 6:00 am EDT
Tenax Therapeutics Announces First Quarter Fiscal Year 2016 Financial Results